Back to Newsroom

Ocata Therapeutics Added to Russell 2000, 3000, Global and Microcap Indices

MARLBOROUGH, Mass.– Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, announced today that the company has been added to the Russell 2000®, 3000®, Russell Global, and Russell Microcap indices.

Click here to read more